Oxytocin-conjugated saporin injected into the substantia nigra of male rats alters the activity of the nigrostriatal dopaminergic system: A behavioral and neurochemical study. 2021

Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy. Electronic address: fabrizio.sanna@unica.it.

Saporin conjugated to oxytocin (OXY-SAP) destroys neurons expressing oxytocinergic receptors. When injected unilaterally in the substantia nigra of male rats, OXY-SAP causes a dose-dependent decrease up to 55 % in nigral Tyrosine Hydroxylase (TH)-immunoreactivity compared to control mock peptide BLANK-SAP- and PBS-treated rats or the contralateral substantia nigra. TH decrease was parallel to a dopamine content decrease in the ipsilateral striatum compared to BLANK-SAP- or PBS-treated rats or the contralateral striatum. OXY-SAP-treated rats showed a small but significant increase of locomotor activity 28 days after intranigral injection in the Open field test compared to BLANK-SAP- or PBS-treated rats, in line with an inhibitory role of nigral oxytocin on locomotor activity. OXY-SAP-, but not BLANK-SAP- or PBS-treated rats, also showed marked dose-dependent rotational turning ipsilateral to the injected substantia nigra when challenged with d-amphetamine, but not with apomorphine. Under isoflurane anesthesia OXY-SAP-treated rats showed levels of extracellular dopamine in the dialysate from the ipsilateral striatum only half those of BLANK-SAP- or PBS-treated rats or the contralateral striatum. When treated with d-amphetamine, OXY-SAP_60/120 rats showed increased extracellular dopamine levels in the dialysate from the ipsilateral striatum two third/one third only of those found in BLANK-SAP- or PBS-treated rats or the contralateral striatum, respectively. These results show that OXY-SAP destroys nigrostriatal dopaminergic neurons expressing oxytocin receptors leading to a reduced striatal dopamine function.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009434 Neural Pathways Neural tracts connecting one part of the nervous system with another. Neural Interconnections,Interconnection, Neural,Interconnections, Neural,Neural Interconnection,Neural Pathway,Pathway, Neural,Pathways, Neural
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000076985 Saporins Type 1 ribosome-inactivating proteins derived from SAPONARIA OFFICINALIS that function through endohydrolysis of the N-glycosidic bond at single ADENOSINE residues of 28S RIBOSOMAL RNA. They are used as IMMUNOTOXINS. RIP Ribosome-Inactivating Protein,Ribosome-Inactivating Protein,SAP5 Protein,SAP6 Protein,Saporin,Saporin 5 Protein,Saporin 6 Protein,Saporin Protein,Saporin-S9 Protein,Protein, RIP Ribosome-Inactivating,RIP Ribosome Inactivating Protein,Ribosome Inactivating Protein,Ribosome-Inactivating Protein, RIP,Saporin S9 Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D013239 Stereotyped Behavior Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive. Behavior, Stereotyped,Behaviors, Stereotyped,Stereotyped Behaviors

Related Publications

Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
January 1986, Neurochemistry international,
Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
October 1994, Brain research,
Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
January 1977, Science (New York, N.Y.),
Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
January 2020, Neurotoxicology,
Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
March 1979, British journal of pharmacology,
Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
February 2009, Annals of the New York Academy of Sciences,
Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
March 1996, Toxicology and applied pharmacology,
Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
August 1991, Brain research bulletin,
Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
April 1995, Journal of applied physiology (Bethesda, Md. : 1985),
Fabrizio Sanna, and Jessica Bratzu, and Laura Angioni, and Maria Pina Sorighe, and Cristina Cocco, and Antonio Argiolas, and Maria Rosaria Melis
November 2002, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!